Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      TSO3 Reports First Quarter 2019 Results


      News provided by

      TSO3 Inc.

      May 06, 2019, 18:04 ET

      Share this article

      Share this article


      QUEBEC CITY and MYRTLE BEACH, SC, May 6, 2019 /PRNewswire/ - TSO3 Inc. (TSX: TOS) ("TSO3" or the "Company"), an innovator in sterilization technology for medical devices in healthcare settings, reported financial results for the first quarter ended March 31, 2019.

      Business Highlights

      TSO3's direct sales force continues to increase market adoption of its technology. In the first quarter of 2019, TSO3 received purchase orders or commitment indications for 14 units of its industry-leading STERIZONE® VP4 Sterilizer and shipped nine sterilizers to end-users. The Company ended the quarter with 75 sterilizers installed at end-user locations, seven that have been shipped but not yet installed, and 28 which are under open purchase orders or commitment indications. 

      "The Company is on a record pace with 35 units sold or committed to within the last two quarters. TSO3 continues to execute on its goal to sell the 230 sterilizers repurchased from our exclusive distributor last year," stated R.M. (Ric) Rumble, President and CEO of TSO3.  "The Company now has over 450 opportunities in our pipeline and is also investing in contracting efforts with Integrated Delivery Networks (IDN's) and Group Purchasing Organizations (GPO's) to provide further access and credibility with acute care facilities in the USA.  We remain singularly focused on commercializing our innovative product and see real signs of progress."

      2019 First Quarter Financial Summary

      • Revenues equaled $1.0 million, compared to $0.3 million in the first quarter of 2018. TSO3 revenues in the first quarter of 2019 reflect sales of sterilizers and related accessories, service and $0.4 million from the sale of consumables directly to end customers. The Company shipped nine sterilizers to hospitals in the first quarter of 2019 as compared to none in the first quarter of 2018.
      • Gross profit was positive $0.4 million, or 39% of revenues, as compared to negative ($0.3) million in the first quarter of 2018. Gross profit in the first quarter of 2019 increased as a result of growth in sterilizers and consumables sales at direct-to-user selling prices rather than the wholesale prices at which the Company sold to its distributor in the first quarter of 2018.
      • Research and Development (R&D) expenses amounted to $0.7 million, as compared to $1.7 million in the first quarter of 2018. The Company reduced its research and development expenditures as it focused more of its investments on selling and marketing activities.
      • Selling, general and administrative (SG&A) includes marketing, sales, service and administrative expenses. SG&A expenses were $2.6 million, which is comparable to the first quarter of 2018.
      • Financial expense was $0.5 million as compared to an immaterial amount in the first quarter of 2018. The Company recorded $0.7 million of accrued interest expense in the first quarter of 2019 related to a $20.0 million debt financing it obtained in August 2018 and a non-cash gain of $0.2 million on the revaluation of the embedded derivative within the Convertible Note associated with this financing.
      • The Company's net loss was $(3.4) million, or $(0.04) per share, as compared to $(4.5) million, or $(0.05) per share in the first quarter of 2018.
      • The Company had $11.3 million in cash and cash equivalents and $18.5 million of debt as of March 31, 2019, as compared to $13.0 million in cash and cash equivalents and $18.0 million of debt at the end of 2018. The Company used $1.6 million for operating activities in the first quarter of 2019.

      Supplemental Non-IFRS Financial Measures

      In addition to IFRS financial measures, management uses non-IFRS financial measures to assess the Company's operational performance. It is likely that the non-IFRS financial measures used by the Company will not be comparable to similar measures reported by other issuers or those used by financial analysts as their measures may have different definitions. The measures used by the Company are intended to provide additional information and should not be considered in isolation or as a substitute for IFRS financial performance measures.

      Generally, a non-IFRS financial measure is a numerical measure of an entity's historical or future financial performance, financial position or cash flows that is neither calculated nor recognized under IFRS. Management believes that such non-IFRS financial measures are important as they provide users of the financial statements with a better understanding of the results of the Company's recurring operations and their related trends, while increasing transparency and clarity into its operating results. Management also believes these measures can be useful in assessing the Company's capacity to discharge its financial obligations.

      Management is assessing its operational performance using supplemental non-IFRS measures which removes significant unusual items that do not reflect the recurring and ongoing operational results and trends.

      IFRS to Non-IFRS adjusted EBITDA Reconciliation




      $000's

      2019

      2018

      Q1

      Q4

      Q3

      Q2

      Q1

      Net loss

      (3,426)

      (2,676)

      (2,104)

      (3,952)

      (4,512)

      Financial expenses (income)

      479

      (1,055)

      (599)

      (12)

      (14)

      Amortization and depreciation

      269

      235

      270

      292

      315

      Write-down of tangible and intangible assets

      -

      1,026

      -

      -

      -

      Share-based compensation expense

      356

      369

      688

      627

      371

      Income taxes

      32

      7

      11

      7

      -

      Adjusted EBITDA

      (2,290)

      (2,094)

      (1,734)

      (3,038)

      (3,840)

      Adjusted EBITDA, is adjusted Earnings before Interest, Taxes, Depreciation, and Amortization (Adjusted EBITDA). Adjusted EBITDA adjusts net income for (1) significant realized and unrealized foreign exchange gains or losses, (2) financial expenses (income), (3) amortization and depreciation expenses (4) share-based compensation expense, (5) write-downs of certain tangible and intangible assets, (6) income taxes, and (7) other significant unusual items.

      Summary of Results

      Periods ended March 31, 2019 and 2018 (Unaudited, IFRS Basis, in thousands of US dollars, except per share amounts)




      First Quarter


      2019

      2018


      $

      $

      Revenues

      960

      255

      Cost of sales

      583

      526

      Gross profit

      377

      (271)




      Expenses



      Research and development

      710

      1,704

      Selling, general and administrative

      2,582

      2,551

      Financial expenses (income)

      479

      (14)

      Total Expenses

      3,771

      4,241

      Net loss before income taxes

      (3,394)

      (4,512)

      Income taxes

      32

      -

      Net loss and comprehensive loss

      (3,426)

      (4,512)

      Weighted average number of outstanding shares (in thousands)

      93,465

      92,877

      Basic and diluted net loss per share

      (0.04)

      (0.05)

      Basic and diluted net comprehensive loss per share

      (0.04)

      (0.05)

      Consolidated Statements of Financial Position

      (Unaudited, IFRS Basis, in thousands of US dollars)





      March 31,
      2019

      December 31,
      2018


      $

      $

      Current Assets



      Cash and Cash Equivalents

      11,268

      12,961

      Accounts Receivable

      944

      1,591

      Inventories

      3,438

      3,534

      Current Tax Assets

      -

      16

      Prepaid Expenses

      340

      261


      15,990

      18,363

      Non-current Assets



      Property, Plant and Equipment

      2,360

      2,039

      Intangible Assets

      1,793

      1,781


      4,153

      3,820


      20,143

      22,183

      Current Liabilities



      Accounts Payable and Accrued Liabilities

      1,882

      1,858

      Warranty Provision

      305

      273

      Current Tax Liabilities

      16

      -

      Lease Liabilities

      139

      -

      Deferred Revenues

      185

      103


      2,557

      2,234

      Non-current Liabilities



      Deferred Tax Liabilities

      51

      51

      Lease Liabilities

      250

      -

      Debt

      17,453

      16,711

      Embedded Derivative

      1,064

      1,319

      Deferred Revenues

      -

      -


      21,345

      20,315

      Equity



      Share Capital

      111,470

      111,470

      Reserve – Share-based Compensation

      8,896

      8,540

      Deficit

      (119,856)

      (116,430)

      Accumulated Other Comprehensive Loss

      (1,712)

      (1,712)


      (1,202)

      1,868


      20,143

      22,183

      Consolidated Statements of Cash Flows

      As of March 31, 2019 and 2018 (Unaudited, IFRS Basis, in thousands of US dollars)




      First Quarter


      2019

      $

      2018

      $

      Cash flows from operating activities



      Net loss

      (3,426)

      (4,512)

      Adjustments for:



      Depreciation and amortization

      269

      315

      Loss on disposal of property, plant and equipment

      7

      -

      Income tax

      32

      -

      Share-based Compensation

      356

      371

      Capitalized interest on long term debt

      714

      -

      Gain on re-measurement at fair-value on embedded derivative

      (255)

      -

      Investment income

      (44)

      (27)


      (2,347)

      (3,853)

      Changes in non-cash operating working capital items

      (657)

      (948)

      Interest received

      (44)

      35

      Cash flows used by operating activities

      (1,646)

      (4,766)

      Cash flows from investing activities



      Disposal of investments

      -

      2,326

      Acquisition of property, plant and equipment

      (8)

      (67)

      Acquisition of intangible assets

      (71)

      (41)

      Proceed from disposal of property, plant and equipment

      4

      -

      Cash flows (used) generated by investing activities

      (75)

      2 218

      Cash flows from financing activities



      Financing fee

      28

      -

      Options exercised

      -

      25

      Cash flows generated by financing activities

      28

      25

      Increase in cash and cash equivalents

      (1,693)

      (2,523)

      Cash and cash equivalents at the beginning

      12,961

      8,044

      Cash and cash equivalents at the end

      11,268

      5,521

      Conference call

      TSO3 President and CEO R.M. (Ric) Rumble and CFO Glen Kayll, will host the conference call, followed by a question and answer period.

      Date:

      Tuesday, May 7, 2019

      Time:

      8:00 a.m. Eastern Daylight Time

      Toll-free dial-in number:

      1-888-231-8191

      International dial-in number:

      1-514-807-9895 (Montreal); 1-647-427-7450 (Toronto)

      Conference ID:

      5423529

      Analysts and institutional investors are invited to participate on the call. Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Danielle Ste-Marie at 1-514-465-6701  

      Other interested parties may listen to the live webcast of the conference call at https://event.on24.com/wcc/r/1993850/97C1DC5ABD2F78F31B0550ECA1263AEF which will be available for replay in the Investors section of the Company's website at www.tso3.com.  

      First Quarter of 2019 Results Disclosure

      The first quarter of 2019 Report is available on TSO3's website at www.tso3.com and will shortly be available on SEDAR (www.sedar.com).

      About the STERIZONE® VP4 Sterilizer

      The STERIZONE VP4 Sterilizer is a low-temperature sterilization system that utilizes the dual sterilants of vaporized hydrogen peroxide (H2O2) and ozone (O3) to achieve terminal sterilization of heat and moisture-sensitive medical devices. Its single pre-programmed cycle can sterilize a large number and wide range of compatible devices, creating a cost-effective sterilization process with error-free cycle selection. The device's unique Dynamic Sterilant Delivery System™ automatically adjusts the quantity of injected sterilant based on the load composition, weight and temperature. This capability removes the guesswork and potential for human error, as there is no need to sort instruments and choose the appropriate cycles as with other machines.

      The STERIZONE® VP4 Sterilizer is the only terminal sterilization method that is FDA cleared to sterilize long, multi-channel flexible endoscopes (with a maximum of four channels) of up to 3.5 meters in length - an industry first for any medical device sterilization process.

      The STERIZONE® VP4 Sterilizer is also the only cleared low temperature sterilizer that can process a mixed load consisting of general instruments, single channel flexible endoscopes, and single or double channel rigid endoscopes in the same cycle with load weights of up to 75 lb.  The ability to run mixed loads significantly reduces labor costs by minimizing the amount of instrument sorting required, while maximizing the device turns (more productivity from increased throughput capacity).

      More information about the STERIZONE® VP4 Sterilizer is available through TSO3's website, under the Products section at www.tso3.com.

      About TSO3

      Founded in 1998, TSO3's activities encompass the sale, production, maintenance, research, development and licensing of sterilization processes, related consumable supplies and accessories for heat-sensitive medical devices. The Company designs products for sterile processing areas in the hospital environment that offer an advantageous replacement solution to other low temperature sterilization processes currently used in hospitals. TSO3 also offers services related to the maintenance of sterilization equipment and compatibility testing of medical devices with such processes.

      For more information about TSO3, visit the Company's website at www.tso3.com.

      The statements in this release and oral statements made by representatives of TSO3 relating to matters that are not historical facts are forward-looking statements that involve certain risks, uncertainties and hypotheses, including, but not limited to, the limited history of sales or distribution of the Company, the evolution in customer demand for the Company's products and services, the plans for sales and marketing including the fact that the Company's customers may not commit to any purchases, the ability of the Company to obtain the required regulatory clearances to market its products, general business and economic conditions, the condition of the financial markets, the ability of TSO3 to obtain financing on favourable terms and other risks and uncertainties. Although TSO3 believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. The complete versions of the cautionary note regarding forward-looking statements as well as a description of the relevant assumptions and risk factors likely to affect TSO3's actual or projected results are included in the Management's Discussion and Analysis for the year ended December 31, 2018, which is available on the Company's website. The forward-looking statements contained in this press release are made as of the date hereof, and TSO3 does not assume any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise unless expressly required by applicable securities laws.

      SOURCE TSO3 Inc.

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.